CorMedix Inc. (CRMD)
6.39
-0.35 (-5.19%)
At close: Mar 31, 2025, 11:35 AM
CorMedix Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
| Revenue | 43.47M | n/a | 65.41K | 190.94K | 239.23K | 283.27K | 429.8K | 329.33K | 224.1K | 210.13K | 189.27K | 2K | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 3.19M | 205.56K | 3.73K | 148.94K | 204.85K | 373.23K | 396.79K | 114.96K | 366.67K | 318.72K | 445.8K | 201.6K | n/a | n/a | n/a | n/a | 1.04M |
| Gross Profit | 40.28M | -205.56K | 61.67K | 42K | 34.38K | -89.97K | 33.01K | 214.36K | -142.57K | -108.59K | -256.52K | -199.6K | n/a | n/a | n/a | n/a | -1.04M |
| Operating Income | -22.36M | -48.96M | -30.62M | -29.44M | -27.22M | -21.01M | -26.86M | -32.92M | -24.76M | -16.65M | -8.9M | -4.92M | -3.04M | -7.25M | -8.51M | -6.06M | -4.82M |
| Interest Income | 2.58M | n/a | 326.02K | 14.4K | 116.06K | 322.67K | 36.62K | 110.71K | 126.77K | 60.39K | 2.71K | 668.00 | 1.97K | 12.04K | 23.44K | 2.13K | 25.9K |
| Pretax Income | -19.32B | -46.34M | -30.29M | -29.46M | -27.2M | -21.49M | -26.83M | -33.01M | -24.64M | -18.19M | -20.45M | -9.13M | -3.43M | -7.21M | -11.19M | -8.12M | -9M |
| Net Income | -17.93M | -46.34M | -29.7M | -28.21M | -22.03M | -16.43M | -26.83M | -33.01M | -24.64M | -18.19M | -20.45M | -9.13M | -3.43M | -6.71M | -10.91M | -8.12M | -9M |
| Selling & General & Admin | 58.7M | 35.8M | 20.01M | 16.35M | 13.88M | 9.87M | 8.07M | 8.65M | 8.88M | 10.26M | 7.33M | 3.49M | 1.86M | 3.15M | 3.01M | 1.17M | 691.89K |
| Research & Development | 3.94M | 13.16M | 10.68M | 13.13M | 13.38M | 11.05M | 18.82M | 24.49M | 15.74M | 6.28M | 1.32M | 1.23M | 1.19M | 4.1M | 5.49M | 4.89M | 3.08M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.51K | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 62.64M | 48.96M | 30.69M | 29.48M | 27.26M | 20.92M | 26.9M | 33.14M | 24.62M | 16.55M | 8.65M | 4.72M | 3.04M | 7.25M | 8.51M | 6.06M | 3.77M |
| Interest Expense | 36.41K | n/a | 26.52K | 15.94K | 33.23K | 787.49K | 1.87K | 5.62K | 1.31K | 3.96K | 2.09K | 1.44M | 382.94K | 12.04K | 3.09M | 2.07M | 4.21M |
| Selling & Marketing Expenses | -28.74B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 65.83M | 48.96M | 30.69M | 29.48M | 27.46M | 21.29M | 27.29M | 33.25M | 24.99M | 16.86M | 9.09M | 4.92M | 3.04M | 7.25M | 8.51M | 6.06M | 4.82M |
| Income Tax | -1.39B | n/a | -585.62K | -1.25M | -5.17M | -5.06M | 36.44K | -31.27K | 1.31K | 3.96K | 2.09K | 1.44M | 1.97K | -493.86K | -280.92K | 2.13K | n/a |
| Shares Outstanding (Basic) | 58.87M | 50.9M | 40.14M | 37.61M | 28.56M | 24.15M | 17.82M | 11.03M | 7.59M | 6.27M | 4.29M | 2.76M | 2.28M | 2.28M | 1.89M | 171.33K | 2.28M |
| Shares Outstanding (Diluted) | 58.87M | 50.9M | 40.27M | 37.67M | 28.56M | 24.15M | 17.82M | 11.03M | 7.59M | 6.27M | 4.29M | 2.76M | 2.28M | 2.28M | 1.89M | 171.33K | 2.28M |
| EPS (Basic) | -304.56 | -0.91 | -0.74 | -0.75 | -0.77 | -0.68 | -1.51 | -2.99 | -3.25 | -2.9 | -4.77 | -3.3 | -1.5 | -2.94 | -5.76 | -47.4 | -3.94 |
| EPS (Diluted) | -304.56 | -0.91 | -0.74 | -0.75 | -0.77 | -0.68 | -1.51 | -2.99 | -3.25 | -2.9 | -4.77 | -3.3 | -1.5 | -2.94 | -5.76 | -47.4 | -3.94 |
| EBITDA | -22.36B | -48.89M | -30.05M | -29.38M | -27.02M | -20.63M | -26.75M | -32.97M | -24.62M | -18.17M | -20.44M | -7.68M | -3.04M | -7.19M | -8.47M | -6.04M | -3.75M |
| Depreciation & Amortization | -22.33B | 70.75K | 209.04K | 177.02K | 143.49K | 73.29K | 74.22K | 36.89K | 25.6K | 15.08K | 15.07K | 5.16K | 7.02K | 12.25K | 12.17K | 9.95K | 1.04M |